carbamazepine has been researched along with cholest-5-ene-3,4-diol in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aden, Y; Bertilsson, L; Bodin, K; Bretillon, L; Broomé, U; Diczfalusy, U; Einarsson, C | 1 |
| Bertilsson, L; Diczfalusy, U; Larsson, H; Wide, K | 1 |
| Rodrigues, AD; Yang, Z | 1 |
| Gjestad, C; Haslemo, T; Huynh, DK; Molden, E | 1 |
| Haslemo, T; Hole, K; Molden, E; Nguyen, C; Wollmann, BM | 1 |
5 other study(ies) available for carbamazepine and cholest-5-ene-3,4-diol
| Article | Year |
|---|---|
Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4.
Topics: Adult; Aged; Animals; Anticonvulsants; Carbamazepine; Cell Line; Cholagogues and Choleretics; Cholesterol; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Female; Humans; Hydroxycholesterols; Insecta; Kinetics; Male; Microsomes; Middle Aged; Mixed Function Oxygenases; Phenobarbital; Phenytoin; Recombinant Proteins; Ursodeoxycholic Acid | 2001 |
Time course of the increase in 4beta-hydroxycholesterol concentration during carbamazepine treatment of paediatric patients with epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cytochrome P-450 CYP3A; Epilepsy; Female; Humans; Hydroxycholesterols; Infant; Male; Treatment Outcome | 2008 |
Does the long plasma half-life of 4beta-hydroxycholesterol impact its utility as a cytochrome P450 3A (CYP3A) metric?
Topics: Biomarkers; Carbamazepine; Computer Simulation; Cytochrome P-450 CYP3A; Enzyme Induction; Enzyme Inhibitors; Half-Life; Humans; Hydroxycholesterols; Models, Biological; Rifampin; Time Factors | 2010 |
4β-hydroxycholesterol correlates with dose but not steady-state concentration of carbamazepine: indication of intestinal CYP3A in biomarker formation?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Biomarkers; Carbamazepine; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Dose-Response Relationship, Drug; Female; Humans; Hydroxycholesterols; Intestines; Male; Middle Aged; Random Allocation; Retrospective Studies; Sex Factors; Young Adult | 2016 |
Comparison of CYP3A4-Inducing Capacity of Enzyme-Inducing Antiepileptic Drugs Using 4β-Hydroxycholesterol as Biomarker.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Biomarkers; Carbamazepine; Cytochrome P-450 CYP3A Inducers; Drug Monitoring; Enzyme Induction; Female; Humans; Hydroxycholesterols; Levetiracetam; Male; Middle Aged; Phenobarbital; Phenytoin; Retrospective Studies; Young Adult | 2018 |